THOMAS F. SELLERS JR., M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: The recent editorial, "Cancer in the Immunosuppressed Patient," by Dr. John L. Fahey (Ann Intern Med 75:310-312, 1971) points out well the possible adverse effect immunosuppression may have in lowering a patient's defenses against malignant tumors.
An additional important point should be made. The editorial cites several references comparing the incidence of certain neoplasms in immunosuppressed patients with the occurrence of such tumors in the general population. At the end of the editorial Dr. Fahey discusses the need for appropriate control populations because of "evidence that certain autoimmune diseases are associated with a high incidence of lymphoma
SELLERS TF. Incidence of Cancer in Immunosuppression. Ann Intern Med. 1971;75:809. doi: https://doi.org/10.7326/0003-4819-75-5-809_1
Download citation file:
Published: Ann Intern Med. 1971;75(5):809.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use